Prevention of Breast Cancer-Related Lymphedema.

Tremendous progress has been made over the past several decades in the treatment of breast cancer. Mortality and recurrence rates continue to decline. Our ability to tailor patient- and tumor-specific treatments has rapidly advanced.

Risk factors associated with severe and recurrent angioedema: an epidemic linked to ACE-inhibitors.

Objectives/hypothesis: To evaluate the etiology and risk factors for severe manifestation and recurrent episodes of angioedema; to evaluate efficacy of short-term and long-term management strategies for angioedema among a high-risk population.

Study Design: Institutional review board-approved retrospective review of a large, urban population.

Methods: Data from 875 adult patients treated from January 2008 to December 2013 with the diagnosis of angioedema were obtained using the Clinical Looking Glass utility and review of medical records.